世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

内視鏡リプロセッシング市場：製品別（HLDおよびテストストリップ、洗浄剤およびワイプ、自動内視鏡リプロセッサー（AER）、内視鏡乾燥・保管・搬送システム、トラッキングソリューション）、エンドユーザー別（病院、ASCおよびクリニック）（2022年〜2027年）


Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 - 2027)

内視鏡の再処理市場は、2022年の24億ドルから2027年には38億ドルに達すると予測されており、2022年から2027年までのCAGRは9.7%です。この市場の成長は、対象疾患の診断と治療のための内視鏡検査の必要性の増加、... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2022年5月11日 US$4,950
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		259 266 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

内視鏡の再処理市場は、2022年の24億ドルから2027年には38億ドルに達すると予測されており、2022年から2027年までのCAGRは9.7%です。この市場の成長は、対象疾患の診断と治療のための内視鏡検査の必要性の増加、内視鏡の汚染による内視鏡関連感染の高いリスク、老齢人口の増加と内視鏡手術の増加、医療機関による再処理のガイドライン改善への重点化によってもたらされると考えています。また、医療インフラや内視鏡の研究分野を改善するための投資、資金、助成金の増加が、予測期間中の市場成長の機会を提供すると予想されます。

"2021年の内視鏡リプロセス市場の製品別シェアは、高水準消毒剤とテストストリップが最大のシェアを占める見込みです。
製品別に見ると、世界の内視鏡リプロセス市場は、高レベル消毒剤およびテストストリップ、洗剤・ワイプ、内視鏡追跡システム、内視鏡乾燥・保管・搬送システム、内視鏡自動リプロセッサー（AER）、その他の製品（ブラシおよびフラッシングエイド、リークテスター、フックアップ、スポンジ）に区分されます。2021年の内視鏡リプロセッシング世界市場では、高水準消毒剤およびテストストリップのセグメントが最大のシェアを占めています。このセグメントの大きなシェアは、高レベルの消毒剤の需要を促進する感染症の発生によるものです。テストストリップは、高レベル消毒剤の推奨最低濃度を効果的に測定するために使用され、消毒剤の反応時間が早く、ユーザーフレンドリーな色比較チャートで残留炭水化物、タンパク質、ヘモグロビンを検出し、内視鏡洗浄手順の成功を監視することができます。

"2021年のエンドユーザー別、内視鏡リプロセッシング市場は病院が最大シェアを占める見込み"
エンドユーザーに基づいて、世界の内視鏡リプロセシング市場は、病院、外来手術センターやクリニック、その他のエンドユーザー（診断センター、移動式内視鏡施設、オフィス内視鏡センター）に区分されます。2021年には、内視鏡処置に関連する病院の患者数が多く、病院における内視鏡リプロセス製品の需要増加につながることから、病院セグメントが最大のシェアを占めています。

"2021年、北米が内視鏡リプロセシング市場で最大のシェアを占めた"
内視鏡リプロセッシング市場は、地域別に、北米、欧州、アジア太平洋、その他の地域に区分されます。2021年、内視鏡リプロセッシング市場では、北米が最大のシェアを占めています。北米の最大シェアは、がん患者数の増加、有利な償還シナリオ、対象疾患の診断と治療のための内視鏡検査の要件の増加などの要因に起因することができます。

供給側の一次インタビュー（企業タイプ別、呼称別、地域別）の内訳。
- 企業タイプ別企業タイプ別：Tier1(20%)、Tier2(45%)、Tier3(35%)
- 役職別Cレベルエグゼクティブ(30%)、ディレクター(20%)、その他(50%)
- 地域別北米 (33%)、欧州 (24%)、アジア太平洋 (27%)、その他の地域 (16%)

主な参入企業は、Advanced Sterilization Products（米国）、オリンパス株式会社（日本）、Ecolab（米国）、STERIS（アイルランド）です。

レポート掲載企業一覧
- キャンテルメディカル(米国)
- アドバンスト・ステリライゼーション・プロダクツ（ASP）（米国）
- オリンパス株式会社（日本）
- エコラボ (米国)
- STERIS (アイルランド)
- ゲティンゲ社（スウェーデン）
- ワッセンブルグメディカル (オランダ)
- コンメッド社（米国）
- ベリメッドAG（スイス）
- エンドテクニーク W. グリーザット（ドイツ）
- カスタム ウルトラソニックス (アメリカ)
- スティールコ S.p.A.(イタリア)
- BESヘルスケア社 (イギリス)
- アークヘルスケアソリューションズ（カナダ）
- メトレックス・リサーチ・エルエルシー(カナダ)
- リチャード・ウルフGmbH（ドイツ）
- MEDALKAN (ギリシャ)
- マイクロサイエンティフィックLLC（米国）
- ボーラーケミーAG（スイス）
- Tuttnauer（オランダ）
- ATMS（カナダ）
- サミット・イメージング社（米国）
- メドニカ Co.LTD（韓国）
- SHINVA MEDICAL INSTRUMENTS CO.LTD（中国）
- メディカルデバイセズグループSrl（イタリア）
調査対象範囲
本レポートでは、製品、エンドユーザー、地域に基づいて内視鏡の再処理市場を調査しています。また、市場成長に影響を与える要因（促進要因、阻害要因、課題、機会など）を分析しています。利害関係者向けに市場の機会や課題を評価し、市場リーダー向けに競争環境の詳細を提供しています。また、マイクロマーケットについては、その成長動向、展望、内視鏡リプロセシング市場全体への貢献度に関して調査しています。本レポートでは、4つの主要地域に関して、市場セグメントの収益を予測しています。

レポート購入の理由
本レポートは、以下のポイントに関する洞察を提供します。

- 市場の浸透。内視鏡の再処理市場のトップ25のプレーヤーによって提供される内視鏡の再処理に関する包括的な情報。このレポートでは、内視鏡の再処理市場の製品、エンドユーザー、地域を分析します。

- 市場開発。有利な新興市場に関する包括的な情報。このレポートでは、主要な地域ごとの様々な固定装置の市場を分析しています。

- 市場の多様化。内視鏡再生処理市場における新製品、未開拓の地域、最近の開発、投資に関する徹底的な情報。

- 競争力の評価。内視鏡の再処理市場における主要企業の市場シェアと戦略に関する詳細な評価

ページTOPに戻る


目次

1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS AND EXCLUSIONS 33
1.3 MARKET SCOPE 34
1.3.1 MARKET SEGMENTATION 34
1.3.2 GEOGRAPHIC SCOPE 34
1.3.3 YEARS CONSIDERED 35
1.4 CURRENCY 35
1.5 LIMITATIONS 35
1.6 STAKEHOLDERS 36
1.7 SUMMARY OF CHANGES 36
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH DATA 38
FIGURE 1 RESEARCH DESIGN 38
2.1.1 SECONDARY DATA 39
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY DATA 40
FIGURE 2 PRIMARY SOURCES 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Key industry insights 42
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS 42
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 43
2.2 MARKET SIZE ESTIMATION 43
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION: BELIMED AG
(A METALL ZUG GROUP COMPANY). 44
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
(SUPPLY SIDE): COLLECTIVE REVENUE OF ENDOSCOPE REPROCESSING PRODUCTS AND SERVICES 44
FIGURE 7 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 45
FIGURE 8 TOP-DOWN APPROACH 46
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 47
FIGURE 9 DATA TRIANGULATION METHODOLOGY 47
2.4 STUDY ASSUMPTIONS 48
2.5 RISK ASSESSMENT/FACTOR ANALYSIS 48
TABLE 1 RISKS 48
 
3 EXECUTIVE SUMMARY 49
FIGURE 10 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2022 VS. 2027 (USD BILLION) 49
FIGURE 11 ENDOSCOPE REPROCESSING MARKET, BY END-USER,
2022 VS. 2027 (USD BILLION) 50
FIGURE 12 ENDOSCOPE REPROCESSING MARKET, BY REGION,
2022 VS. 2027 (USD BILLION) 51
4 PREMIUM INSIGHTS 52
4.1 ENDOSCOPE REPROCESSING MARKET OVERVIEW 52
FIGURE 13 RISING INCIDENCE OF TARGET DISEASES AND SUBSEQUENT INCREASE IN ENDOSCOPIC PROCEDURES TO DRIVE MARKET GROWTH 52
4.2 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SHARE, BY PRODUCT (2021) 53
FIGURE 14 HIGH-LEVEL DISINFECTANTS AND TEST STRIPS SEGMENT TO DOMINATE MARKET IN 2021 53
4.3 GEOGRAPHICAL SNAPSHOT OF ENDOSCOPE REPROCESSING MARKET 54
FIGURE 15 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 16 ENDOSCOPE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 56
5.2.1.1 Increasing requirement for endoscopy to diagnose
and treat target diseases 56
5.2.1.2 High risk of endoscope-associated infections 56
5.2.1.3 Growing geriatric population and subsequent increase
in endoscopic procedures 57
5.2.1.4 Increasing emphasis on improving reprocessing guidelines
by healthcare authorities 58
5.2.1.5 Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy 59
TABLE 2 MAJOR DEVELOPMENTS 59
5.2.1.6 Increasing preference for minimally invasive surgeries 59
5.2.1.7 Rising focus of medical specialists and healthcare providers on shifting from manual to automated endoscopy reprocessing 60
5.2.2 RESTRAINTS 61
5.2.2.1 Concerns related to reprocessed instrument safety 61
5.2.2.2 Adverse effects of chemical disinfectants 61
5.2.2.3 High overhead costs of endoscopy procedures with limited reimbursement in developing countries 62
5.2.2.4 High risk of COVID-19 transmission during endoscopic procedures 62
 
5.2.3 OPPORTUNITIES 63
5.2.3.1 Growing medical devices industry in emerging economies 63
FIGURE 17 MEDICAL DEVICES MARKET, 2016-2020 (USD BILLION) 64
5.2.4 CHALLENGES 64
5.2.4.1 Preference for single-use endoscopes 64
5.2.4.2 Increasing number of product failures and recalls 65
5.2.4.3 Shortage of trained professionals 65
5.2.4.4 Lack of awareness associated with reprocessing methods 66
5.2.4.5 Increasing FDA recommended measures to
reduce infection transmission 66
5.3 COVID-19 IMPACT ANALYSIS 67
FIGURE 18 PERCENTAGE OF ENDOSCOPY PROCEDURES/PER WEEK
BEFORE AND DURING COVID-19 67
5.4 RANGES/ SCENARIOS 68
5.4.1 ENDOSCOPE REPROCESSING MARKET 68
FIGURE 19 REALISTIC SCENARIO OF ENDOSCOPE REPROCESSING MARKET 68
FIGURE 20 PESSIMISTIC SCENARIO OF THE ENDOSCOPE REPROCESSING MARKET 69
FIGURE 21 OPTIMISTIC SCENARIO OF ENDOSCOPE REPROCESSING MARKET 69
5.5 REGULATORY ANALYSIS 70
TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING
MEDICAL DEVICE REPROCESSING 70
5.5.1 NORTH AMERICA 70
5.5.1.1 US 70
FIGURE 22 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR
REPROCESSED MEDICAL DEVICES 71
5.5.1.2 Canada 71
TABLE 4 CANADA: REPROCESSING POLICIES OF SINGLE-USE MEDICAL DEVICES 72
5.5.2 EUROPE 73
FIGURE 23 CE MARKING FOR REPROCESSED MEDICAL DEVICES 73
5.5.2.1 Germany 73
5.5.2.2 Rest of Europe 74
5.5.3 ASIA PACIFIC 74
5.5.3.1 Japan 74
5.5.3.2 Australia 74
5.5.3.3 Rest of Asia Pacific 74
5.5.4 LATIN AMERICA 75
5.5.5 MIDDLE EAST & AFRICA 75
5.6 PORTER’S FIVE FORCES ANALYSIS 75
5.6.1 THREAT FROM NEW ENTRANTS 76
5.6.2 BARGAINING POWER OF SUPPLIERS 76
5.6.3 BARGAINING POWER OF BUYERS 76
5.6.4 INTENSITY OF COMPETITIVE RIVALRY 76
5.6.5 THREAT FROM SUBSTITUTES 77
5.7 SUPPLY CHAIN ANALYSIS 77
FIGURE 24 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES 78
5.8 VALUE CHAIN ANALYSIS 78
FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED
DURING MANUFACTURING AND ASSEMBLY PHASES 78
5.9 ECOSYSTEM ANALYSIS 79
FIGURE 26 ENDOSCOPE REPROCESSING MARKET: ECOSYSTEM ANALYSIS 79
5.9.1 ROLE IN ECOSYSTEM 80
FIGURE 27 KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET ECOSYSTEM 80
5.10 TECHNOLOGY ANALYSIS 81
5.11 KEY CONFERENCES & EVENTS IN 2022-2023 82
TABLE 5 ENDOSCOPE REPROCESSING MARKET: DETAILED LIST
OF CONFERENCES & EVENTS 82
5.12 PATENT ANALYSIS 83
5.12.1 PATENT GRANTED TRENDS FOR ENDOSCOPE REPROCESSORS 84
FIGURE 28 PATENT GRANTED TRENDS OF AUTOMATED ENDOSCOPE REPROCESSORS, JANUARY 2011– APRIL 2022 84
FIGURE 29 PATENT GRANTED TRENDS OF HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, JANUARY 2011– FEBRUARY 2022 85
FIGURE 30 PATENT GRANTED TRENDS OF ENDOSCOPE TRACKING SYSTEMS, JANUARY 2011– APRIL 2022 85
5.12.2 JURISDICTION AND TOP APPLICANT ANALYSIS 86
FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR AUTOMATED ENDOSCOPE REPROCESSORS PATENTS,
JANUARY 2011—APRIL 2022 86
FIGURE 32 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, JANUARY 2011—APRIL 2022 87
FIGURE 33 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ENDOSCOPE TRACKING SYSTEMS, JANUARY 2011— APRIL 2022 88
5.13 TRADE ANALYSIS 88
5.13.1 IMPORT DATA FOR HS CODE 841920, BY COUNTRY,
2016–2021 (USD MILLION) 89
5.13.2 EXPORT DATA FOR HS CODE 841920, BY COUNTRY,
2016–2021 (USD MILLION) 89
5.13.3 EXPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–2021 90
5.13.4 IMPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–2021 90
5.14 PRICING ANALYSIS 91
TABLE 6 AVERAGE SELLING PRICES OF ENDOSCOPE REPROCESSING EQUIPMENT 91
TABLE 7 AVERAGE SELLING PRICE FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY COUNTRY 91
TABLE 8 COST OF CONSUMABLES INVOLVED IN REPROCESSING ENDOSCOPES WITH MANUAL CLEANING PLUS AER 92
TABLE 9 TOTAL ESTIMATED COST FOR REPROCESSING ONE FLEXIBLE ENDOSCOPE 93
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 93
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 93
FIGURE 34 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS 93
TABLE 10 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS (%) 94
5.15.2 BUYING CRITERIA 94
FIGURE 35 KEY BUYING CRITERIA FOR END USERS 94
TABLE 11 KEY BUYING CRITERIA FOR END USERS 95
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 95
5.16.1 REVENUE SHIFT & REVENUE POCKETS FOR ENDOSCOPE REPROCESSING MANUFACTURERS 95
FIGURE 36 REVENUE SHIFT FOR ENDOSCOPE REPROCESSING 96
6 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT 97
6.1 INTRODUCTION 98
TABLE 12 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 98
TABLE 13 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 99
6.2 HIGH-LEVEL DISINFECTANTS AND TEST STRIPS 99
6.2.1 OUTBREAK OF INFECTIOUS DISEASES TO DRIVE HIGH-LEVEL DISINFECTANTS AND TEST STRIPS DEMAND 99
TABLE 14 ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2017–2020 (USD MILLION) 100
TABLE 15 ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2021–2027 (USD MILLION) 100
6.3 DETERGENTS & WIPES 101
6.3.1 INCREASING EMPHASIS ON PRE-CLEANING METHODS
TO PROPEL SEGMENT GROWTH 101
TABLE 16 ENDOSCOPE REPROCESSING MARKET DETERGENTS & WIPES,
BY REGION, 2017–2020 (USD MILLION) 101
TABLE 17 ENDOSCOPE REPROCESSING MARKET FOR DETERGENTS & WIPES,
BY REGION, 2021–2027 (USD MILLION) 102
6.4 AUTOMATED ENDOSCOPE REPROCESSORS 102
6.4.1 INCREASED EFFICIENCY OF AUTOMATED ENDOSCOPE REPROCESSORS OVER MANUAL CLEANING TO DRIVE MARKET GROWTH 102
TABLE 18 MANUFACTURERS AND RESPECTIVE AUTOMATED ENDOSCOPE REPROCESSOR MODELS 103
TABLE 19 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2017–2020 (USD MILLION) 104
TABLE 20 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2021–2027 (USD MILLION) 104
6.4.2 AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY 105
6.4.2.1 Introduction 105
TABLE 21 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY, 2017–2020 (USD MILLION) 105
TABLE 22 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY, 2021–2027 (USD MILLION) 105
6.4.2.2 Standalone AER 105
TABLE 23 ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2017–2020 (USD MILLION) 106
TABLE 24 ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2021–2027 (USD MILLION) 106
6.4.2.3 Portable AER 106
TABLE 25 ENDOSCOPE REPROCESSING MARKET FOR PORTABLE AER, BY REGION, 2017–2020 (USD MILLION) 107
TABLE 26 ENDOSCOPE REPROCESSING MARKET FOR PORTABLE AER, BY REGION, 2021–2027 (USD MILLION) 107
6.4.3 AUTOMATED ENDOSCOPE REPROCESSORS, BY TYPE 107
TABLE 27 ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE,
2017–2020 (USD MILLION) 108
TABLE 28 ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE,
2021–2027 (USD MILLION) 108
6.4.3.1 Single-basin AER 108
TABLE 29 MANUFACTURERS AND RESPECTIVE AER MODELS, BY TYPE (SINGLE BASIN) 108
6.4.3.2 Double-basin AER 109
TABLE 30 MANUFACTURERS AND RESPECTIVE AER MODELS, BY TYPE (DUAL BASIN) 109
6.5 ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS 109
6.5.1 GUIDELINES FOR DRYING, STORAGE, AND TRANSPORTATION OF REPROCESSED ENDOSCOPES TO DRIVE MARKET GROWTH 109
TABLE 31 ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS OFFERED 110
TABLE 32 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2017–2020 (USD MILLION) 111
TABLE 33 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2021–2027 (USD MILLION) 111
6.6 ENDOSCOPE TRACKING SYSTEMS 112
6.6.1 RISING FOCUS ON REPROCESSING TO DRIVE SEGMENT GROWTH 112
TABLE 34 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SYSTEMS, BY REGION, 2017–2020 (USD MILLION) 113
TABLE 35 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SYSTEMS, BY REGION, 2021–2027 (USD MILLION) 113
6.7 OTHER PRODUCTS 114
TABLE 36 OTHER PRODUCTS OFFERED BY MANUFACTURERS 115
TABLE 37 ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS,
BY REGION, 2017–2020 (USD MILLION) 116
TABLE 38 ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS,
BY REGION, 2021–2027 (USD MILLION) 116
7 ENDOSCOPE REPROCESSING MARKET, BY END USER 117
7.1 INTRODUCTION 118
TABLE 39 ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 118
TABLE 40 ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 118
7.2 HOSPITALS 119
7.2.1 LARGE PATIENT VOLUME IN HOSPITALS TO INCREASE DEMAND FOR ENDOSCOPE REPROCESSING PRODUCTS 119
TABLE 41 ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION,
2017–2020 (USD MILLION) 120
TABLE 42 ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION,
2021–2027 (USD MILLION) 120
7.3 AMBULATORY SURGERY CENTERS AND CLINICS 121
7.3.1 COST-EFFECTIVENESS OF AMBULATORY SURGERY CENTERS AND CLINICS TO DRIVE MARKET GROWTH 121
TABLE 43 NUMBER OF MEDICARE-CERTIFIED AMBULATORY SURGERY
CENTERS IN US, 2013–2017 121
TABLE 44 TOTAL AMBULATORY SURGERY CENTER PROCEDURES IN US, 2015–2021 122
TABLE 45 ENDOSCOPE REPROCESSING MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION, 2017–2020 (USD MILLION) 123
TABLE 46 ENDOSCOPE REPROCESSING MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION, 2021–2027 (USD MILLION) 123
7.4 OTHER END USERS 124
TABLE 47 ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS,
BY REGION, 2017–2020 (USD MILLION) 124
TABLE 48 ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS,
BY REGION, 2021–2027 (USD MILLION) 125
8 ENDOSCOPE REPROCESSING MARKET, BY REGION 126
8.1 INTRODUCTION 127
TABLE 49 ENDOSCOPE REPROCESSING MARKET, BY REGION,
2017–2020 (USD MILLION) 127
TABLE 50 ENDOSCOPE REPROCESSING MARKET, BY REGION,
2021–2027 (USD MILLION) 127
8.2 NORTH AMERICA 128
FIGURE 37 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET SNAPSHOT 128
TABLE 51 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 129
TABLE 52 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2021–2027 (USD MILLION) 129
TABLE 53 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 130
TABLE 54 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION) 130
TABLE 55 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 131
TABLE 56 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 131
TABLE 57 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION) 131
TABLE 58 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION) 132
8.2.1 US 132
8.2.1.1 Favorable reimbursement scenario to propel market growth 132
TABLE 59 MEDICARE NATIONAL AVERAGE COVERAGE FOR
OUTPATIENT PROCEDURES, 2021 132
TABLE 60 US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 134
TABLE 61 US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 134
TABLE 62 US: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 135
TABLE 63 US: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 135
TABLE 64 US: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 135
TABLE 65 US: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 136
8.2.2 CANADA 136
8.2.2.1 High prevalence of hospital-acquired infections to drive market growth 136
TABLE 66 CANADA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 137
TABLE 67 CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 137
TABLE 68 CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 138
TABLE 69 CANADA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 138
TABLE 70 CANADA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 139
TABLE 71 CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 139
TABLE 72 CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 139
8.3 EUROPE 140
TABLE 73 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 140
TABLE 74 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2021–2027 (USD MILLION) 140
TABLE 75 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 141
TABLE 76 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 141
TABLE 77 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 142
TABLE 78 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 142
TABLE 79 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 142
TABLE 80 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 143
8.3.1 GERMANY 143
8.3.1.1 Increased surgical procedures to propel market growth 143
TABLE 81 GERMANY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 144
TABLE 82 GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 144
TABLE 83 GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 145
TABLE 84 GERMANY ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 145
TABLE 85 GERMANY ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 146
TABLE 86 GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 146
TABLE 87 GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 146
8.3.2 UK 147
8.3.2.1 Increasing use of endoscopy procedures to drive market growth 147
FIGURE 38 MEAN PERCENTAGE CHANGE IN ENDOSCOPE PROCEDURE NUMBERS BETWEEN 2017 AND 2019 148
TABLE 88 UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 149
TABLE 89 UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 149
TABLE 90 UK: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 150
TABLE 91 UK: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 150
TABLE 92 UK: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 150
TABLE 93 UK: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 151
8.3.3 FRANCE 151
8.3.3.1 Increasing prevalence of cancer to support market growth 151
TABLE 94 FRANCE: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 152
TABLE 95 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 152
TABLE 96 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 153
TABLE 97 FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 153
TABLE 98 FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 154
TABLE 99 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 154
TABLE 100 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 154
8.3.4 ITALY 155
8.3.4.1 Growing geriatric population to support market growth 155
TABLE 101 ITALY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 155
TABLE 102 ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 156
TABLE 103 ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 156
TABLE 104 ITALY: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 157
TABLE 105 ITALY: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 157
TABLE 106 ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 157
TABLE 107 ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 158
8.3.5 SPAIN 158
8.3.5.1 Developing healthcare infrastructure to support market growth 158
TABLE 108 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 159
TABLE 109 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 159
TABLE 110 SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 160
TABLE 111 SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 160
TABLE 112 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 160
TABLE 113 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 161
8.3.6 REST OF EUROPE 161
TABLE 114 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 162
TABLE 115 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION) 162
TABLE 116 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 163
TABLE 117 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 163
TABLE 118 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION) 163
TABLE 119 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION) 164
8.4 ASIA PACIFIC 164
FIGURE 39 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SNAPSHOT 165
TABLE 120 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 166
TABLE 121 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2021–2027 (USD MILLION) 166
TABLE 122 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 167
TABLE 123 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 167
TABLE 124 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 168
TABLE 125 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 168
TABLE 126 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 168
TABLE 127 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 169
8.4.1 JAPAN 169
8.4.1.1 Increasing use of endoscopes to drive market growth 169
TABLE 128 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 170
TABLE 129 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 171
TABLE 130 JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 171
TABLE 131 JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 172
TABLE 132 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 172
TABLE 133 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 172
8.4.2 CHINA 173
8.4.2.1 Rising prevalence of cancer to increase endoscopic procedures 173
TABLE 134 CHINA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 173
TABLE 135 CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 174
TABLE 136 CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 174
TABLE 137 CHINA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 175
TABLE 138 CHINA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 175
TABLE 139 CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 175
TABLE 140 CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 176
8.4.3 INDIA 176
8.4.3.1 Developing healthcare infrastructure to support market growth 176
TABLE 141 INDIA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 177
TABLE 142 INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 177
TABLE 143 INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 178
TABLE 144 INDIA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 178
TABLE 145 INDIA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 179
TABLE 146 INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 179
TABLE 147 INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 179
8.4.4 REST OF ASIA PACIFIC 180
TABLE 148 INCIDENCE OF CANCER IN REST OF ASIA PACIFIC COUNTRIES 180
TABLE 149 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 181
TABLE 150 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION) 181
TABLE 151 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2017–2020 (USD MILLION) 182
TABLE 152 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2021–2027 (USD MILLION) 182
TABLE 153 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION) 182
TABLE 154 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION) 183
8.5 REST OF THE WORLD 183
TABLE 155 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2017–2020 (USD MILLION) 183
TABLE 156 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2021–2027 (USD MILLION) 184
TABLE 157 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 184
TABLE 158 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION) 185
TABLE 159 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2017–2020 (USD MILLION) 185
TABLE 160 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2021–2027 (USD MILLION) 186
TABLE 161 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION) 186
TABLE 162 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION) 186
8.5.1 LATIN AMERICA 187
8.5.1.1 Rising prevalence of infections due to endoscopy-related procedures to support market growth 187
TABLE 163 LUNG CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 188
TABLE 164 LIVER CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 188
TABLE 165 BREAST CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 188
TABLE 166 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 189
TABLE 167 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 189
TABLE 168 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 190
TABLE 169 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 190
TABLE 170 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION) 190
TABLE 171 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION) 191
8.5.2 MIDDLE EAST & AFRICA 191
8.5.2.1 Introduction of regulatory frameworks for medical equipment reprocessing to drive market growth 191
TABLE 172 AFRICA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 192
TABLE 173 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET,
BY PRODUCT, 2017–2020 (USD MILLION) 192
TABLE 174 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET,
BY PRODUCT, 2021–2027 (USD MILLION) 193
TABLE 175 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2017–2020 (USD MILLION) 193
TABLE 176 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2021–2027 (USD MILLION) 194
TABLE 177 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION) 194
TABLE 178 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION) 194
9 COMPETITIVE LANDSCAPE 195
9.1 OVERVIEW 195
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 195
TABLE 179 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS 195
9.3 REVENUE ANALYSIS 196
FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN ENDOSCOPE
REPROCESSING MARKET 197
9.4 MARKET SHARE ANALYSIS 197
FIGURE 41 ENDOSCOPE REPROCESSING MARKET SHARE ANALYSIS, 2020 198
TABLE 180 ENDOSCOPE REPROCESSING MARKET: DEGREE OF COMPETITION 198
9.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS) 200
9.5.1 STARS 200
9.5.2 EMERGING LEADERS 200
9.5.3 PERVASIVE PLAYERS 200
9.5.4 PARTICIPANTS 200
FIGURE 42 VENDOR DIVE: ENDOSCOPE REPROCESSING MARKET 201
 
9.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES) 202
9.6.1 PROGRESSIVE COMPANIES 202
9.6.2 STARTING BLOCKS 202
9.6.3 RESPONSIVE COMPANIES 202
9.6.4 DYNAMIC COMPANIES 202
FIGURE 43 ENDOSCOPE REPROCESSING MARKET: VENDOR DIVE MATRIX FOR SMES AND START-UPS, 2020 203
9.6.4.1 COMPETITIVE BENCHMARKING 204
TABLE 181 ENDOSCOPE REPROCESSING MARKET: DETAILED LIST OF KEY STARTUP/SMES 204
TABLE 182 ENDOSCOPE REPROCESSING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [STARTUPS/SMES] 205
9.7 COMPANY FOOTPRINT 206
TABLE 183 COMPANY FOOTPRINT 206
TABLE 184 COMPANY PRODUCT FOOTPRINT 207
TABLE 185 COMPANY GEOGRAPHICAL FOOTPRINT 208
9.8 COMPETITIVE SCENARIO AND TRENDS 209
9.8.1 DEALS 209
TABLE 186 DEALS, JANUARY 2019- APRIL 2022 209
9.8.2 PRODUCT LAUNCHES & APPROVALS 210
TABLE 187 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019- APRIL 2022 210
9.8.3 EXPANSIONS 211
TABLE 188 EXPANSIONS, JANUARY 2019- APRIL 2022 211
10 COMPANY PROFILES 212
10.1 KEY PLAYERS 212
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
10.1.1 CANTEL MEDICAL 212
TABLE 189 CANTEL MEDICAL: BUSINESS OVERVIEW 212
FIGURE 44 CANTEL MEDICAL: COMPANY SNAPSHOT (2020) 213
10.1.2 ADVANCED STERILIZATION PRODUCTS (FORTIVE) 217
TABLE 190 ADVANCED STERILIZATION PRODUCTS (FORTIVE): BUSINESS OVERVIEW 217
FIGURE 45 ADVANCED STERILIZATION PRODUCTS (FORTIVE):
COMPANY SNAPSHOT (2020) 218
10.1.3 OLYMPUS CORPORATION 221
TABLE 191 OLYMPUS CORPORATION: BUSINESS OVERVIEW 221
FIGURE 46 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020) 222
10.1.4 ECOLAB 225
TABLE 192 ECOLAB: BUSINESS OVERVIEW 225
FIGURE 47 ECOLAB: COMPANY SNAPSHOT (2021) 226
10.1.5 STERIS 229
TABLE 193 STERIS: BUSINESS OVERVIEW 229
FIGURE 48 STERIS: COMPANY SNAPSHOT (2020) 230
10.1.6 GETINGE AB 234
TABLE 194 GETINGE AB: BUSINESS OVERVIEW 234
FIGURE 49 GETINGE AB: COMPANY SNAPSHOT (2021) 235
10.1.7 WASSENBURG MEDICAL (A MEMBER OF HOYA) 239
TABLE 195 WASSENBURG MEDICAL (A MEMBER OF HOYA): BUSINESS OVERVIEW 239
FIGURE 50 WASSENBURG MEDICAL (A MEMBER OF HOYA):
COMPANY SNAPSHOT (2020) 239
10.1.8 CONMED CORPORATION 241
TABLE 196 CONMED CORPORATION: BUSINESS OVERVIEW 241
FIGURE 51 CONMED CORPORATION: COMPANY SNAPSHOT (2021) 242
10.1.9 BELIMED AG (A METALL ZUG GROUP COMPANY) 243
TABLE 197 BELIMED AG (METALL ZUG GROUP COMPANY): BUSINESS OVERVIEW 243
FIGURE 52 BELIMED AG (METALL ZUG GROUP COMPANY): COMPANY SNAPSHOT (2021) 244
10.1.10 ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL) 246
TABLE 198 ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL): BUSINESS OVERVIEW 246
FIGURE 53 ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL):
COMPANY SNAPSHOT (2020) 246
10.1.11 CUSTOM ULTRASONICS 249
TABLE 199 CUSTOM ULTRASONICS: BUSINESS OVERVIEW 249
10.1.12 STEELCO S.P.A 250
TABLE 200 STEELCO S.P.A: BUSINESS OVERVIEW 250
10.1.13 BES HEALTHCARE (A DIVISION OF BES REHAB LTD) 252
TABLE 201 BES HEALTHCARE: BUSINESS OVERVIEW 252
10.1.14 ARC HEALTHCARE SOLUTIONS 253
TABLE 202 ARC HEALTHCARE SOLUTIONS: BUSINESS OVERVIEW 253
10.1.15 METREX RESEARCH, LLC 254
TABLE 203 METREX RESEARCH. LLC: BUSINESS OVERVIEW 254
10.2 OTHER PLAYERS 255
10.2.1 RICHARD WOLF GMBH 255
TABLE 204 RICHARD WOLF GMBH: BUSINESS OVERVIEW 255
10.2.2 MEDALKAN 255
TABLE 205 MEDALKAN: BUSINESS OVERVIEW 255
10.2.3 MICRO-SCIENTIFIC, LLC 256
TABLE 206 MICRO-SCIENTIFIC, LLC: BUSINESS OVERVIEW 256
10.2.4 BORER CHEMIE AG 256
TABLE 207 BORER CHEMIE AG: BUSINESS OVERVIEW 256
10.2.5 MEDONICA CO. LTD 257
TABLE 208 MEDONICA CO. LTD: BUSINESS OVERVIEW 257
10.2.6 TUTTNAUER 257
TABLE 209 TUTTNAUER: BUSINESS OVERVIEW 257
10.2.7 ATMS 258
TABLE 210 ATMS: BUSINESS OVERVIEW 258
10.2.8 SUMMIT IMAGING, INC. 258
TABLE 211 SUMMIT IMAGING, INC.: BUSINESS OVERVIEW 258
10.2.9 SHINVA MEDICAL INSTRUMENT CO., LTD 259
TABLE 212 SHINVA MEDICAL INSTRUMENT CO., LTD: BUSINESS OVERVIEW 259
10.2.10 MEDICAL DEVICES GROUP SRL 259
TABLE 213 MEDICAL DEVICES GROUP SRL: BUSINESS OVERVIEW 259
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
11 APPENDIX 260
11.1 DISCUSSION GUIDE 260
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 264
11.3 AVAILABLE CUSTOMIZATIONS 266
11.4 RELATED REPORTS 266
11.5 AUTHOR DETAILS 267

　

ページTOPに戻る


　

Summary

The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to iIncreasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during the forecast period.

“High-level disinfectants and test stripsare expected to hold the largest share of the endoscope reprocessing market, by product in 2021.”
Based on product, the global endoscope reprocessing market is segmented into high-level disinfectants and test strips; detergents & wipes; endoscope tracking systems; endoscope drying, storage, and transport systems; automated endoscope reprocessors (AERs); and other products (brushes and flushing aids, leak testers, hookups, and sponges). In 2021, the high-level disinfectants and test strips segment holds the largest share of the global endoscope reprocessing market. The large share of this segment is due to outbreak of infectious diseases to drive high-level disinfectants demand. Test strips are used to effectively measure the minimum recommended concentration of high-level disinfectants and provide fast disinfectant reaction time and a user-friendly color comparison chart to detect residual carbohydrate, protein, and hemoglobin to monitor the success of endoscope cleaning procedures.

“Hospitals are expected to hold the largest share of the endoscope reprocessing market, by end user in 2021.”
Based on end users, the global endoscope reprocessing market is segmented into hospitals, ambulatory surgery centers and clinics, and other end users (diagnostic centers, mobile endoscopy facilities, and office endoscopy centers). In 2021, the hospitals' segment has the largest share due to large patient volume in hospitals related to endoscopic procedures leads to increase demand for endoscope reprocessing products in hospitals.

“North America commanded the largest share of the endoscope reprocessing market in 2021.”
Based on region, the endoscope reprocessing market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2021, North America has the largest share of the endoscope reprocessing market. The largest share of North America can be attributed to factors such as the rising number of cancer cases, favorable reimbursement scenarios, and Increasing requirement for endoscopy to diagnose and treat target diseases.

Breakdown of supply-side primary interviews, by company type, designation, and region:
• By Company Type: Tier 1 (20%), Tier 2(45%), and Tier 3 (35%)
• By Designation: C-level Executives (30%), Directors (20%), and Others (50%)
• By Region: North America (33%), Europe (24%), AsiaPacific(27%), and Rest of the World (16%)

Some of the major players operating in this market areAdvanced Sterilization Products(US), Olympus Corporation (Japan), Ecolab(US), and STERIS(Ireland)

List of Companies Profiled in the Report
• Cantel Medical (US)
• Advanced Sterilization Products (ASP) (US)
• Olympus Corporation (Japan)
• Ecolab (US)
• STERIS (Ireland)
• Getinge AB (Sweden)
• Wassenburg Medical (Netherlands)
• CONMED Corporation (US)
• Belimed AG (Switzerland)
• Endo-Technik W. Griesat (Germany)
• Custom Ultrasonics (US)
• Steelco S.p.A. (Italy)
• BES Healthcare Ltd (UK)
• ARC Healthcare Solutions (Canada)
• Metrex Research, LLC. (Canada)
• Richard Wolf GmbH (Germany)
• MEDALKAN (Greece)
• Micro-Scientific, LLC (US)
• Borer Chemie AG (Switzerland)
• Tuttnauer (Netherlands)
• ATMS (Canada)
• Summit Imaging, Inc. (US)
• Medonica Co. LTD (South Korea)
• SHINVA MEDICAL INSTRUMENT CO. LTD (China)
• Medical Devices Group Srl (Italy)
Research Coverage
This report studies the endoscope reprocessing market based on product, end user, and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total endoscope reprocessing market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on endoscope reprocessingoffered by the top 25 players in the endoscope reprocessing market. The report analyzes the endoscope reprocessing marketproduct, end user,and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devicesacross key geographic regions.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the endoscope reprocessing market

• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the endoscope reprocessing market



ページTOPに戻る


Table of Contents

1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS AND EXCLUSIONS 33
1.3 MARKET SCOPE 34
1.3.1 MARKET SEGMENTATION 34
1.3.2 GEOGRAPHIC SCOPE 34
1.3.3 YEARS CONSIDERED 35
1.4 CURRENCY 35
1.5 LIMITATIONS 35
1.6 STAKEHOLDERS 36
1.7 SUMMARY OF CHANGES 36
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH DATA 38
FIGURE 1 RESEARCH DESIGN 38
2.1.1 SECONDARY DATA 39
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY DATA 40
FIGURE 2 PRIMARY SOURCES 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Key industry insights 42
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND
DEMAND SIDE PARTICIPANTS 42
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 43
2.2 MARKET SIZE ESTIMATION 43
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION: BELIMED AG
(A METALL ZUG GROUP COMPANY). 44
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
(SUPPLY SIDE): COLLECTIVE REVENUE OF ENDOSCOPE REPROCESSING PRODUCTS AND SERVICES 44
FIGURE 7 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 45
FIGURE 8 TOP-DOWN APPROACH 46
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 47
FIGURE 9 DATA TRIANGULATION METHODOLOGY 47
2.4 STUDY ASSUMPTIONS 48
2.5 RISK ASSESSMENT/FACTOR ANALYSIS 48
TABLE 1 RISKS 48
 
3 EXECUTIVE SUMMARY 49
FIGURE 10 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2022 VS. 2027 (USD BILLION) 49
FIGURE 11 ENDOSCOPE REPROCESSING MARKET, BY END-USER,
2022 VS. 2027 (USD BILLION) 50
FIGURE 12 ENDOSCOPE REPROCESSING MARKET, BY REGION,
2022 VS. 2027 (USD BILLION) 51
4 PREMIUM INSIGHTS 52
4.1 ENDOSCOPE REPROCESSING MARKET OVERVIEW 52
FIGURE 13 RISING INCIDENCE OF TARGET DISEASES AND SUBSEQUENT INCREASE IN ENDOSCOPIC PROCEDURES TO DRIVE MARKET GROWTH 52
4.2 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SHARE, BY PRODUCT (2021) 53
FIGURE 14 HIGH-LEVEL DISINFECTANTS AND TEST STRIPS SEGMENT TO DOMINATE MARKET IN 2021 53
4.3 GEOGRAPHICAL SNAPSHOT OF ENDOSCOPE REPROCESSING MARKET 54
FIGURE 15 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 16 ENDOSCOPE REPROCESSING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 56
5.2.1.1 Increasing requirement for endoscopy to diagnose
and treat target diseases 56
5.2.1.2 High risk of endoscope-associated infections 56
5.2.1.3 Growing geriatric population and subsequent increase
in endoscopic procedures 57
5.2.1.4 Increasing emphasis on improving reprocessing guidelines
by healthcare authorities 58
5.2.1.5 Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy 59
TABLE 2 MAJOR DEVELOPMENTS 59
5.2.1.6 Increasing preference for minimally invasive surgeries 59
5.2.1.7 Rising focus of medical specialists and healthcare providers on shifting from manual to automated endoscopy reprocessing 60
5.2.2 RESTRAINTS 61
5.2.2.1 Concerns related to reprocessed instrument safety 61
5.2.2.2 Adverse effects of chemical disinfectants 61
5.2.2.3 High overhead costs of endoscopy procedures with limited reimbursement in developing countries 62
5.2.2.4 High risk of COVID-19 transmission during endoscopic procedures 62
 
5.2.3 OPPORTUNITIES 63
5.2.3.1 Growing medical devices industry in emerging economies 63
FIGURE 17 MEDICAL DEVICES MARKET, 2016-2020 (USD BILLION) 64
5.2.4 CHALLENGES 64
5.2.4.1 Preference for single-use endoscopes 64
5.2.4.2 Increasing number of product failures and recalls 65
5.2.4.3 Shortage of trained professionals 65
5.2.4.4 Lack of awareness associated with reprocessing methods 66
5.2.4.5 Increasing FDA recommended measures to
reduce infection transmission 66
5.3 COVID-19 IMPACT ANALYSIS 67
FIGURE 18 PERCENTAGE OF ENDOSCOPY PROCEDURES/PER WEEK
BEFORE AND DURING COVID-19 67
5.4 RANGES/ SCENARIOS 68
5.4.1 ENDOSCOPE REPROCESSING MARKET 68
FIGURE 19 REALISTIC SCENARIO OF ENDOSCOPE REPROCESSING MARKET 68
FIGURE 20 PESSIMISTIC SCENARIO OF THE ENDOSCOPE REPROCESSING MARKET 69
FIGURE 21 OPTIMISTIC SCENARIO OF ENDOSCOPE REPROCESSING MARKET 69
5.5 REGULATORY ANALYSIS 70
TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING
MEDICAL DEVICE REPROCESSING 70
5.5.1 NORTH AMERICA 70
5.5.1.1 US 70
FIGURE 22 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR
REPROCESSED MEDICAL DEVICES 71
5.5.1.2 Canada 71
TABLE 4 CANADA: REPROCESSING POLICIES OF SINGLE-USE MEDICAL DEVICES 72
5.5.2 EUROPE 73
FIGURE 23 CE MARKING FOR REPROCESSED MEDICAL DEVICES 73
5.5.2.1 Germany 73
5.5.2.2 Rest of Europe 74
5.5.3 ASIA PACIFIC 74
5.5.3.1 Japan 74
5.5.3.2 Australia 74
5.5.3.3 Rest of Asia Pacific 74
5.5.4 LATIN AMERICA 75
5.5.5 MIDDLE EAST & AFRICA 75
5.6 PORTER’S FIVE FORCES ANALYSIS 75
5.6.1 THREAT FROM NEW ENTRANTS 76
5.6.2 BARGAINING POWER OF SUPPLIERS 76
5.6.3 BARGAINING POWER OF BUYERS 76
5.6.4 INTENSITY OF COMPETITIVE RIVALRY 76
5.6.5 THREAT FROM SUBSTITUTES 77
5.7 SUPPLY CHAIN ANALYSIS 77
FIGURE 24 DIRECT DISTRIBUTION—PREFERRED STRATEGY OF PROMINENT COMPANIES 78
5.8 VALUE CHAIN ANALYSIS 78
FIGURE 25 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED
DURING MANUFACTURING AND ASSEMBLY PHASES 78
5.9 ECOSYSTEM ANALYSIS 79
FIGURE 26 ENDOSCOPE REPROCESSING MARKET: ECOSYSTEM ANALYSIS 79
5.9.1 ROLE IN ECOSYSTEM 80
FIGURE 27 KEY PLAYERS IN ENDOSCOPE REPROCESSING MARKET ECOSYSTEM 80
5.10 TECHNOLOGY ANALYSIS 81
5.11 KEY CONFERENCES & EVENTS IN 2022-2023 82
TABLE 5 ENDOSCOPE REPROCESSING MARKET: DETAILED LIST
OF CONFERENCES & EVENTS 82
5.12 PATENT ANALYSIS 83
5.12.1 PATENT GRANTED TRENDS FOR ENDOSCOPE REPROCESSORS 84
FIGURE 28 PATENT GRANTED TRENDS OF AUTOMATED ENDOSCOPE REPROCESSORS, JANUARY 2011– APRIL 2022 84
FIGURE 29 PATENT GRANTED TRENDS OF HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, JANUARY 2011– FEBRUARY 2022 85
FIGURE 30 PATENT GRANTED TRENDS OF ENDOSCOPE TRACKING SYSTEMS, JANUARY 2011– APRIL 2022 85
5.12.2 JURISDICTION AND TOP APPLICANT ANALYSIS 86
FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR AUTOMATED ENDOSCOPE REPROCESSORS PATENTS,
JANUARY 2011—APRIL 2022 86
FIGURE 32 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, JANUARY 2011—APRIL 2022 87
FIGURE 33 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ENDOSCOPE TRACKING SYSTEMS, JANUARY 2011— APRIL 2022 88
5.13 TRADE ANALYSIS 88
5.13.1 IMPORT DATA FOR HS CODE 841920, BY COUNTRY,
2016–2021 (USD MILLION) 89
5.13.2 EXPORT DATA FOR HS CODE 841920, BY COUNTRY,
2016–2021 (USD MILLION) 89
5.13.3 EXPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–2021 90
5.13.4 IMPORT DATA FOR HS CODE 841920, BY COUNTRY, 2016–2021 90
5.14 PRICING ANALYSIS 91
TABLE 6 AVERAGE SELLING PRICES OF ENDOSCOPE REPROCESSING EQUIPMENT 91
TABLE 7 AVERAGE SELLING PRICE FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY COUNTRY 91
TABLE 8 COST OF CONSUMABLES INVOLVED IN REPROCESSING ENDOSCOPES WITH MANUAL CLEANING PLUS AER 92
TABLE 9 TOTAL ESTIMATED COST FOR REPROCESSING ONE FLEXIBLE ENDOSCOPE 93
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 93
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 93
FIGURE 34 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS 93
TABLE 10 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS (%) 94
5.15.2 BUYING CRITERIA 94
FIGURE 35 KEY BUYING CRITERIA FOR END USERS 94
TABLE 11 KEY BUYING CRITERIA FOR END USERS 95
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 95
5.16.1 REVENUE SHIFT & REVENUE POCKETS FOR ENDOSCOPE REPROCESSING MANUFACTURERS 95
FIGURE 36 REVENUE SHIFT FOR ENDOSCOPE REPROCESSING 96
6 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT 97
6.1 INTRODUCTION 98
TABLE 12 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 98
TABLE 13 ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 99
6.2 HIGH-LEVEL DISINFECTANTS AND TEST STRIPS 99
6.2.1 OUTBREAK OF INFECTIOUS DISEASES TO DRIVE HIGH-LEVEL DISINFECTANTS AND TEST STRIPS DEMAND 99
TABLE 14 ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2017–2020 (USD MILLION) 100
TABLE 15 ENDOSCOPE REPROCESSING MARKET FOR HIGH-LEVEL DISINFECTANTS AND TEST STRIPS, BY REGION, 2021–2027 (USD MILLION) 100
6.3 DETERGENTS & WIPES 101
6.3.1 INCREASING EMPHASIS ON PRE-CLEANING METHODS
TO PROPEL SEGMENT GROWTH 101
TABLE 16 ENDOSCOPE REPROCESSING MARKET DETERGENTS & WIPES,
BY REGION, 2017–2020 (USD MILLION) 101
TABLE 17 ENDOSCOPE REPROCESSING MARKET FOR DETERGENTS & WIPES,
BY REGION, 2021–2027 (USD MILLION) 102
6.4 AUTOMATED ENDOSCOPE REPROCESSORS 102
6.4.1 INCREASED EFFICIENCY OF AUTOMATED ENDOSCOPE REPROCESSORS OVER MANUAL CLEANING TO DRIVE MARKET GROWTH 102
TABLE 18 MANUFACTURERS AND RESPECTIVE AUTOMATED ENDOSCOPE REPROCESSOR MODELS 103
TABLE 19 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2017–2020 (USD MILLION) 104
TABLE 20 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2021–2027 (USD MILLION) 104
6.4.2 AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY 105
6.4.2.1 Introduction 105
TABLE 21 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY, 2017–2020 (USD MILLION) 105
TABLE 22 ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSORS, BY PORTABILITY, 2021–2027 (USD MILLION) 105
6.4.2.2 Standalone AER 105
TABLE 23 ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2017–2020 (USD MILLION) 106
TABLE 24 ENDOSCOPE REPROCESSING MARKET FOR STANDALONE AER, BY REGION, 2021–2027 (USD MILLION) 106
6.4.2.3 Portable AER 106
TABLE 25 ENDOSCOPE REPROCESSING MARKET FOR PORTABLE AER, BY REGION, 2017–2020 (USD MILLION) 107
TABLE 26 ENDOSCOPE REPROCESSING MARKET FOR PORTABLE AER, BY REGION, 2021–2027 (USD MILLION) 107
6.4.3 AUTOMATED ENDOSCOPE REPROCESSORS, BY TYPE 107
TABLE 27 ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE,
2017–2020 (USD MILLION) 108
TABLE 28 ENDOSCOPE REPROCESSING MARKET FOR AER, BY TYPE,
2021–2027 (USD MILLION) 108
6.4.3.1 Single-basin AER 108
TABLE 29 MANUFACTURERS AND RESPECTIVE AER MODELS, BY TYPE (SINGLE BASIN) 108
6.4.3.2 Double-basin AER 109
TABLE 30 MANUFACTURERS AND RESPECTIVE AER MODELS, BY TYPE (DUAL BASIN) 109
6.5 ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS 109
6.5.1 GUIDELINES FOR DRYING, STORAGE, AND TRANSPORTATION OF REPROCESSED ENDOSCOPES TO DRIVE MARKET GROWTH 109
TABLE 31 ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS OFFERED 110
TABLE 32 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2017–2020 (USD MILLION) 111
TABLE 33 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE DRYING, STORAGE, & TRANSPORT SYSTEMS, BY REGION, 2021–2027 (USD MILLION) 111
6.6 ENDOSCOPE TRACKING SYSTEMS 112
6.6.1 RISING FOCUS ON REPROCESSING TO DRIVE SEGMENT GROWTH 112
TABLE 34 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SYSTEMS, BY REGION, 2017–2020 (USD MILLION) 113
TABLE 35 ENDOSCOPE REPROCESSING MARKET FOR ENDOSCOPE TRACKING SYSTEMS, BY REGION, 2021–2027 (USD MILLION) 113
6.7 OTHER PRODUCTS 114
TABLE 36 OTHER PRODUCTS OFFERED BY MANUFACTURERS 115
TABLE 37 ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS,
BY REGION, 2017–2020 (USD MILLION) 116
TABLE 38 ENDOSCOPE REPROCESSING MARKET FOR OTHER PRODUCTS,
BY REGION, 2021–2027 (USD MILLION) 116
7 ENDOSCOPE REPROCESSING MARKET, BY END USER 117
7.1 INTRODUCTION 118
TABLE 39 ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 118
TABLE 40 ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 118
7.2 HOSPITALS 119
7.2.1 LARGE PATIENT VOLUME IN HOSPITALS TO INCREASE DEMAND FOR ENDOSCOPE REPROCESSING PRODUCTS 119
TABLE 41 ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION,
2017–2020 (USD MILLION) 120
TABLE 42 ENDOSCOPE REPROCESSING MARKET FOR HOSPITALS, BY REGION,
2021–2027 (USD MILLION) 120
7.3 AMBULATORY SURGERY CENTERS AND CLINICS 121
7.3.1 COST-EFFECTIVENESS OF AMBULATORY SURGERY CENTERS AND CLINICS TO DRIVE MARKET GROWTH 121
TABLE 43 NUMBER OF MEDICARE-CERTIFIED AMBULATORY SURGERY
CENTERS IN US, 2013–2017 121
TABLE 44 TOTAL AMBULATORY SURGERY CENTER PROCEDURES IN US, 2015–2021 122
TABLE 45 ENDOSCOPE REPROCESSING MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION, 2017–2020 (USD MILLION) 123
TABLE 46 ENDOSCOPE REPROCESSING MARKET FOR AMBULATORY SURGERY CENTERS AND CLINICS, BY REGION, 2021–2027 (USD MILLION) 123
7.4 OTHER END USERS 124
TABLE 47 ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS,
BY REGION, 2017–2020 (USD MILLION) 124
TABLE 48 ENDOSCOPE REPROCESSING MARKET FOR OTHER END USERS,
BY REGION, 2021–2027 (USD MILLION) 125
8 ENDOSCOPE REPROCESSING MARKET, BY REGION 126
8.1 INTRODUCTION 127
TABLE 49 ENDOSCOPE REPROCESSING MARKET, BY REGION,
2017–2020 (USD MILLION) 127
TABLE 50 ENDOSCOPE REPROCESSING MARKET, BY REGION,
2021–2027 (USD MILLION) 127
8.2 NORTH AMERICA 128
FIGURE 37 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET SNAPSHOT 128
TABLE 51 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2017–2020 (USD MILLION) 129
TABLE 52 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY, 2021–2027 (USD MILLION) 129
TABLE 53 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 130
TABLE 54 NORTH AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION) 130
TABLE 55 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 131
TABLE 56 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 131
TABLE 57 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION) 131
TABLE 58 NORTH AMERICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION) 132
8.2.1 US 132
8.2.1.1 Favorable reimbursement scenario to propel market growth 132
TABLE 59 MEDICARE NATIONAL AVERAGE COVERAGE FOR
OUTPATIENT PROCEDURES, 2021 132
TABLE 60 US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 134
TABLE 61 US ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 134
TABLE 62 US: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 135
TABLE 63 US: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 135
TABLE 64 US: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 135
TABLE 65 US: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 136
8.2.2 CANADA 136
8.2.2.1 High prevalence of hospital-acquired infections to drive market growth 136
TABLE 66 CANADA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 137
TABLE 67 CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 137
TABLE 68 CANADA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 138
TABLE 69 CANADA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 138
TABLE 70 CANADA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 139
TABLE 71 CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 139
TABLE 72 CANADA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 139
8.3 EUROPE 140
TABLE 73 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 140
TABLE 74 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2021–2027 (USD MILLION) 140
TABLE 75 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 141
TABLE 76 EUROPE ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 141
TABLE 77 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 142
TABLE 78 EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 142
TABLE 79 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 142
TABLE 80 EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 143
8.3.1 GERMANY 143
8.3.1.1 Increased surgical procedures to propel market growth 143
TABLE 81 GERMANY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 144
TABLE 82 GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 144
TABLE 83 GERMANY ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 145
TABLE 84 GERMANY ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 145
TABLE 85 GERMANY ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 146
TABLE 86 GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 146
TABLE 87 GERMANY ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 146
8.3.2 UK 147
8.3.2.1 Increasing use of endoscopy procedures to drive market growth 147
FIGURE 38 MEAN PERCENTAGE CHANGE IN ENDOSCOPE PROCEDURE NUMBERS BETWEEN 2017 AND 2019 148
TABLE 88 UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 149
TABLE 89 UK: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 149
TABLE 90 UK: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 150
TABLE 91 UK: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 150
TABLE 92 UK: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 150
TABLE 93 UK: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 151
8.3.3 FRANCE 151
8.3.3.1 Increasing prevalence of cancer to support market growth 151
TABLE 94 FRANCE: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 152
TABLE 95 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 152
TABLE 96 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 153
TABLE 97 FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 153
TABLE 98 FRANCE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 154
TABLE 99 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 154
TABLE 100 FRANCE: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 154
8.3.4 ITALY 155
8.3.4.1 Growing geriatric population to support market growth 155
TABLE 101 ITALY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 155
TABLE 102 ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 156
TABLE 103 ITALY: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 156
TABLE 104 ITALY: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 157
TABLE 105 ITALY: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 157
TABLE 106 ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 157
TABLE 107 ITALY: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 158
8.3.5 SPAIN 158
8.3.5.1 Developing healthcare infrastructure to support market growth 158
TABLE 108 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 159
TABLE 109 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 159
TABLE 110 SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 160
TABLE 111 SPAIN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 160
TABLE 112 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 160
TABLE 113 SPAIN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 161
8.3.6 REST OF EUROPE 161
TABLE 114 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 162
TABLE 115 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION) 162
TABLE 116 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 163
TABLE 117 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 163
TABLE 118 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION) 163
TABLE 119 REST OF EUROPE: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION) 164
8.4 ASIA PACIFIC 164
FIGURE 39 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET SNAPSHOT 165
TABLE 120 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2017–2020 (USD MILLION) 166
TABLE 121 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY COUNTRY,
2021–2027 (USD MILLION) 166
TABLE 122 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 167
TABLE 123 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 167
TABLE 124 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 168
TABLE 125 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 168
TABLE 126 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 168
TABLE 127 ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 169
8.4.1 JAPAN 169
8.4.1.1 Increasing use of endoscopes to drive market growth 169
TABLE 128 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 170
TABLE 129 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 171
TABLE 130 JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 171
TABLE 131 JAPAN: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 172
TABLE 132 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 172
TABLE 133 JAPAN: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 172
8.4.2 CHINA 173
8.4.2.1 Rising prevalence of cancer to increase endoscopic procedures 173
TABLE 134 CHINA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 173
TABLE 135 CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 174
TABLE 136 CHINA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 174
TABLE 137 CHINA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 175
TABLE 138 CHINA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 175
TABLE 139 CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 175
TABLE 140 CHINA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 176
8.4.3 INDIA 176
8.4.3.1 Developing healthcare infrastructure to support market growth 176
TABLE 141 INDIA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 177
TABLE 142 INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 177
TABLE 143 INDIA: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 178
TABLE 144 INDIA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 178
TABLE 145 INDIA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 179
TABLE 146 INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2017–2020 (USD MILLION) 179
TABLE 147 INDIA: ENDOSCOPE REPROCESSING MARKET, BY END USER,
2021–2027 (USD MILLION) 179
8.4.4 REST OF ASIA PACIFIC 180
TABLE 148 INCIDENCE OF CANCER IN REST OF ASIA PACIFIC COUNTRIES 180
TABLE 149 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 181
TABLE 150 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION) 181
TABLE 151 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2017–2020 (USD MILLION) 182
TABLE 152 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2021–2027 (USD MILLION) 182
TABLE 153 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION) 182
TABLE 154 REST OF ASIA PACIFIC: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION) 183
8.5 REST OF THE WORLD 183
TABLE 155 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2017–2020 (USD MILLION) 183
TABLE 156 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY REGION, 2021–2027 (USD MILLION) 184
TABLE 157 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2017–2020 (USD MILLION) 184
TABLE 158 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET, BY PRODUCT, 2021–2027 (USD MILLION) 185
TABLE 159 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2017–2020 (USD MILLION) 185
TABLE 160 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2021–2027 (USD MILLION) 186
TABLE 161 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION) 186
TABLE 162 REST OF THE WORLD: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION) 186
8.5.1 LATIN AMERICA 187
8.5.1.1 Rising prevalence of infections due to endoscopy-related procedures to support market growth 187
TABLE 163 LUNG CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 188
TABLE 164 LIVER CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 188
TABLE 165 BREAST CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025 188
TABLE 166 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2017–2020 (USD MILLION) 189
TABLE 167 LATIN AMERICA ENDOSCOPE REPROCESSING MARKET, BY PRODUCT,
2021–2027 (USD MILLION) 189
TABLE 168 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2017–2020 (USD MILLION) 190
TABLE 169 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY, 2021–2027 (USD MILLION) 190
TABLE 170 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2017–2020 (USD MILLION) 190
TABLE 171 LATIN AMERICA: ENDOSCOPE REPROCESSING MARKET, BY END USER, 2021–2027 (USD MILLION) 191
8.5.2 MIDDLE EAST & AFRICA 191
8.5.2.1 Introduction of regulatory frameworks for medical equipment reprocessing to drive market growth 191
TABLE 172 AFRICA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025 192
TABLE 173 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET,
BY PRODUCT, 2017–2020 (USD MILLION) 192
TABLE 174 MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET,
BY PRODUCT, 2021–2027 (USD MILLION) 193
TABLE 175 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2017–2020 (USD MILLION) 193
TABLE 176 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET FOR AUTOMATED ENDOSCOPE REPROCESSOR, BY PORTABILITY,
2021–2027 (USD MILLION) 194
TABLE 177 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2017–2020 (USD MILLION) 194
TABLE 178 MIDDLE EAST & AFRICA: ENDOSCOPE REPROCESSING MARKET,
BY END USER, 2021–2027 (USD MILLION) 194
9 COMPETITIVE LANDSCAPE 195
9.1 OVERVIEW 195
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 195
TABLE 179 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURERS 195
9.3 REVENUE ANALYSIS 196
FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN ENDOSCOPE
REPROCESSING MARKET 197
9.4 MARKET SHARE ANALYSIS 197
FIGURE 41 ENDOSCOPE REPROCESSING MARKET SHARE ANALYSIS, 2020 198
TABLE 180 ENDOSCOPE REPROCESSING MARKET: DEGREE OF COMPETITION 198
9.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS) 200
9.5.1 STARS 200
9.5.2 EMERGING LEADERS 200
9.5.3 PERVASIVE PLAYERS 200
9.5.4 PARTICIPANTS 200
FIGURE 42 VENDOR DIVE: ENDOSCOPE REPROCESSING MARKET 201
 
9.6 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES) 202
9.6.1 PROGRESSIVE COMPANIES 202
9.6.2 STARTING BLOCKS 202
9.6.3 RESPONSIVE COMPANIES 202
9.6.4 DYNAMIC COMPANIES 202
FIGURE 43 ENDOSCOPE REPROCESSING MARKET: VENDOR DIVE MATRIX FOR SMES AND START-UPS, 2020 203
9.6.4.1 COMPETITIVE BENCHMARKING 204
TABLE 181 ENDOSCOPE REPROCESSING MARKET: DETAILED LIST OF KEY STARTUP/SMES 204
TABLE 182 ENDOSCOPE REPROCESSING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [STARTUPS/SMES] 205
9.7 COMPANY FOOTPRINT 206
TABLE 183 COMPANY FOOTPRINT 206
TABLE 184 COMPANY PRODUCT FOOTPRINT 207
TABLE 185 COMPANY GEOGRAPHICAL FOOTPRINT 208
9.8 COMPETITIVE SCENARIO AND TRENDS 209
9.8.1 DEALS 209
TABLE 186 DEALS, JANUARY 2019- APRIL 2022 209
9.8.2 PRODUCT LAUNCHES & APPROVALS 210
TABLE 187 PRODUCT LAUNCHES & APPROVALS, JANUARY 2019- APRIL 2022 210
9.8.3 EXPANSIONS 211
TABLE 188 EXPANSIONS, JANUARY 2019- APRIL 2022 211
10 COMPANY PROFILES 212
10.1 KEY PLAYERS 212
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
10.1.1 CANTEL MEDICAL 212
TABLE 189 CANTEL MEDICAL: BUSINESS OVERVIEW 212
FIGURE 44 CANTEL MEDICAL: COMPANY SNAPSHOT (2020) 213
10.1.2 ADVANCED STERILIZATION PRODUCTS (FORTIVE) 217
TABLE 190 ADVANCED STERILIZATION PRODUCTS (FORTIVE): BUSINESS OVERVIEW 217
FIGURE 45 ADVANCED STERILIZATION PRODUCTS (FORTIVE):
COMPANY SNAPSHOT (2020) 218
10.1.3 OLYMPUS CORPORATION 221
TABLE 191 OLYMPUS CORPORATION: BUSINESS OVERVIEW 221
FIGURE 46 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020) 222
10.1.4 ECOLAB 225
TABLE 192 ECOLAB: BUSINESS OVERVIEW 225
FIGURE 47 ECOLAB: COMPANY SNAPSHOT (2021) 226
10.1.5 STERIS 229
TABLE 193 STERIS: BUSINESS OVERVIEW 229
FIGURE 48 STERIS: COMPANY SNAPSHOT (2020) 230
10.1.6 GETINGE AB 234
TABLE 194 GETINGE AB: BUSINESS OVERVIEW 234
FIGURE 49 GETINGE AB: COMPANY SNAPSHOT (2021) 235
10.1.7 WASSENBURG MEDICAL (A MEMBER OF HOYA) 239
TABLE 195 WASSENBURG MEDICAL (A MEMBER OF HOYA): BUSINESS OVERVIEW 239
FIGURE 50 WASSENBURG MEDICAL (A MEMBER OF HOYA):
COMPANY SNAPSHOT (2020) 239
10.1.8 CONMED CORPORATION 241
TABLE 196 CONMED CORPORATION: BUSINESS OVERVIEW 241
FIGURE 51 CONMED CORPORATION: COMPANY SNAPSHOT (2021) 242
10.1.9 BELIMED AG (A METALL ZUG GROUP COMPANY) 243
TABLE 197 BELIMED AG (METALL ZUG GROUP COMPANY): BUSINESS OVERVIEW 243
FIGURE 52 BELIMED AG (METALL ZUG GROUP COMPANY): COMPANY SNAPSHOT (2021) 244
10.1.10 ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL) 246
TABLE 198 ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL): BUSINESS OVERVIEW 246
FIGURE 53 ENDO-TECHNIK W. GRIESAT GMBH (CREO MEDICAL):
COMPANY SNAPSHOT (2020) 246
10.1.11 CUSTOM ULTRASONICS 249
TABLE 199 CUSTOM ULTRASONICS: BUSINESS OVERVIEW 249
10.1.12 STEELCO S.P.A 250
TABLE 200 STEELCO S.P.A: BUSINESS OVERVIEW 250
10.1.13 BES HEALTHCARE (A DIVISION OF BES REHAB LTD) 252
TABLE 201 BES HEALTHCARE: BUSINESS OVERVIEW 252
10.1.14 ARC HEALTHCARE SOLUTIONS 253
TABLE 202 ARC HEALTHCARE SOLUTIONS: BUSINESS OVERVIEW 253
10.1.15 METREX RESEARCH, LLC 254
TABLE 203 METREX RESEARCH. LLC: BUSINESS OVERVIEW 254
10.2 OTHER PLAYERS 255
10.2.1 RICHARD WOLF GMBH 255
TABLE 204 RICHARD WOLF GMBH: BUSINESS OVERVIEW 255
10.2.2 MEDALKAN 255
TABLE 205 MEDALKAN: BUSINESS OVERVIEW 255
10.2.3 MICRO-SCIENTIFIC, LLC 256
TABLE 206 MICRO-SCIENTIFIC, LLC: BUSINESS OVERVIEW 256
10.2.4 BORER CHEMIE AG 256
TABLE 207 BORER CHEMIE AG: BUSINESS OVERVIEW 256
10.2.5 MEDONICA CO. LTD 257
TABLE 208 MEDONICA CO. LTD: BUSINESS OVERVIEW 257
10.2.6 TUTTNAUER 257
TABLE 209 TUTTNAUER: BUSINESS OVERVIEW 257
10.2.7 ATMS 258
TABLE 210 ATMS: BUSINESS OVERVIEW 258
10.2.8 SUMMIT IMAGING, INC. 258
TABLE 211 SUMMIT IMAGING, INC.: BUSINESS OVERVIEW 258
10.2.9 SHINVA MEDICAL INSTRUMENT CO., LTD 259
TABLE 212 SHINVA MEDICAL INSTRUMENT CO., LTD: BUSINESS OVERVIEW 259
10.2.10 MEDICAL DEVICES GROUP SRL 259
TABLE 213 MEDICAL DEVICES GROUP SRL: BUSINESS OVERVIEW 259
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
11 APPENDIX 260
11.1 DISCUSSION GUIDE 260
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 264
11.3 AVAILABLE CUSTOMIZATIONS 266
11.4 RELATED REPORTS 266
11.5 AUTHOR DETAILS 267

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（automated）の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/10/04　10:27

147.72 円

163.39 円

196.69 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.